Vetera GoldXPThis page contains information on Vetera GoldXP for veterinary use.
The information provided typically includes the following:
- Vetera GoldXP Indications
- Warnings and cautions for Vetera GoldXP
- Direction and dosage information for Vetera GoldXP
Vetera GoldXPThis treatment applies to the following species:
Encephalomyelitis-Rhinopneumonitis-Influenza-West Nile Virus Vaccine
Eastern & Western, Killed Virus
Vetera GoldXP Indications
For vaccination of healthy horses 4 months of age or older as an aid in the prevention of disease caused by Eastern and Western Encephalomyelitis, and tetanus; as an aid in the prevention of viremia and mortality, and an aid in the reduction of severity of clinical disease caused by West Nile Virus; as an aid in the reduction of respiratory disease caused by Equine Herpesvirus types 1 and 4 (EHV-1 and EHV-4); and as an aid in the reduction of respiratory disease and shedding caused by A2 Equine Influenza virus. Product contains Kentucky Lineage (KY/95), Florida sublineage clade 1 (OH/03), and Florida sublineage clade 2 (RI/07) equine influenza strains. Efficacy (DOI) has been demonstrated for at least 6 months against OH/03. The duration of immunity against West Nile Virus is at least 12 months.
Administration and dosage: Shake well before use. Using aseptic technique, inoculate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3-4 weeks using a different injection site. Revaccinate annually and prior to anticipated exposure with a single 1 mL intramuscular dose.
PrecautionsStore at 35 - 45°F (2 - 7°C). Protect from freezing. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur following use. Antidote: Epinephrine.
This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy in normal, healthy, immunocompetent animals. This level of performance may be affected by conditions such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies, or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions.
Preservatives: Gentamicin and Amphotericin B.
For Veterinary Use Only
Vetera® is a registered trademark of Boehringer Ingelheim Vetmedica GMBH.
© 2013 Boehringer Ingelheim Vetmedica, Inc. All Rights Reserved.
Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506
US Vet. Lic. No. 124
US Patent No. 7572620. Used under license.
1 Dose/1 mL
10 Doses/10 mL
NAC No.: 1028268.1
2621 NORTH BELT HIGHWAY, ST. JOSEPH, MO, 64506-2002
|Every effort has been made to ensure the accuracy of the Vetera GoldXP information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-07-10